Fig. 4From: Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosisTnf and C5ar1 transcripts are reduced in lumbar spinal cord of anti-HMGB1 antibody-treated SOD1G93A mice. SOD1G93A mice were intraperitoneally injected weekly with the anti-HMGB1 antibody at 35 days of age (100 μg). Pro-inflammatory cytokines (TNFα and IL-1β) and major innate immune receptors (RAGE, C5aR1 and TLR4) in vehicle and anti-HMGB1-treated SOD1G93A mice was investigated at mid-symptomatic stage of disease (133 days) using quantitative PCR. a Show anti-HMGB1 treatment reduces pro-inflammatory cytokine Tnf in the spinal cord of SOD1G93A mice (n = 6, **p < 0.01, Student’s t test), while no change in Il1β was evident between isotype control and anti-HMGB1-treated SOD1G93A mice (b; n = 6, p > 0.05, Student’s t test). Anti-HMGB1 treatment showed slight reduction in C5ar1 mRNA transcript levels while no change was observed for Ager and Tlr4 (c–e; n = 6, *p < 0.05, Student’s t test). Data are presented as mean ± SEMBack to article page